688799 华纳药厂
已收盘 03-27 15:00:01
资讯
新帖
简况
3月27日华纳药厂涨10.05%,安信医药健康股票A基金重仓该股
证券之星 · 16:14
3月27日华纳药厂涨10.05%,安信医药健康股票A基金重仓该股
华纳药厂(688799)披露控股股东增加一致行动人及在一致行动人内部协议转让股份暨权益变动的提示性公告,3月24日股价上涨1.8%
证券之星 · 03-24 22:27
华纳药厂(688799)披露控股股东增加一致行动人及在一致行动人内部协议转让股份暨权益变动的提示性公告,3月24日股价上涨1.8%
华纳药厂最新公告:获得二甲双胍恩格列净片药品注册证书
证券之星 · 03-24 19:11
华纳药厂最新公告:获得二甲双胍恩格列净片药品注册证书
每周股票复盘:华纳药厂(688799)子公司通过美国FDA现场检查
证券之星 · 03-22
每周股票复盘:华纳药厂(688799)子公司通过美国FDA现场检查
华纳药厂(688799)披露关于子公司通过美国FDA现场检查的公告,XX月XX日股价上涨0.39%
证券之星 · 03-16
华纳药厂(688799)披露关于子公司通过美国FDA现场检查的公告,XX月XX日股价上涨0.39%
华纳药厂最新公告:子公司手性药物公司通过美国FDA现场检查
证券之星 · 03-15
华纳药厂最新公告:子公司手性药物公司通过美国FDA现场检查
每周股票复盘:华纳药厂(688799)子公司获巴西GMP认证
证券之星 · 03-01
每周股票复盘:华纳药厂(688799)子公司获巴西GMP认证
股市必读:华纳药厂发布2025年度业绩快报,盈利2.415亿元
证券之星 · 02-24
股市必读:华纳药厂发布2025年度业绩快报,盈利2.415亿元
每周股票复盘:华纳药厂(688799)2025年净利增46.95%
证券之星 · 02-15
每周股票复盘:华纳药厂(688799)2025年净利增46.95%
华纳药厂(688799.SH)2025年度归母净利润2.41亿元,同比增长46.95%
智通财经 · 02-13
华纳药厂(688799.SH)2025年度归母净利润2.41亿元,同比增长46.95%
华纳药厂(688799.SH)参与国家组织集采药品协议期满品种接续采购拟中选
智通财经网 · 02-12
华纳药厂(688799.SH)参与国家组织集采药品协议期满品种接续采购拟中选
每周股票复盘:华纳药厂(688799)ZG-002片Ⅰ期临床研究完成
证券之星 · 02-08
每周股票复盘:华纳药厂(688799)ZG-002片Ⅰ期临床研究完成
华纳药厂(688799.SH)参股公司收到ZG-002片Ⅰ期临床研究报告
智通财经 · 02-05
华纳药厂(688799.SH)参股公司收到ZG-002片Ⅰ期临床研究报告
华纳药厂(688799)披露关于撤回利多卡因凝胶贴膏药品注册申请的公告,1月27日股价下跌2.8%
证券之星 · 01-27
华纳药厂(688799)披露关于撤回利多卡因凝胶贴膏药品注册申请的公告,1月27日股价下跌2.8%
1月22日华纳药厂涨6.52%,安信医药健康股票A基金重仓该股
证券之星 · 01-22
1月22日华纳药厂涨6.52%,安信医药健康股票A基金重仓该股
【机构调研记录】农银汇理基金调研华纳药厂
证券之星 · 2025-12-31
【机构调研记录】农银汇理基金调研华纳药厂
华纳药厂(688799)披露变更注册资本及公司治理结构调整公告,12月26日股价下跌2.2%
证券之星 · 2025-12-26
华纳药厂(688799)披露变更注册资本及公司治理结构调整公告,12月26日股价下跌2.2%
华纳药厂(688799)披露关于获得药品注册证书的公告,12月25日股价下跌0.2%
证券之星 · 2025-12-25
华纳药厂(688799)披露关于获得药品注册证书的公告,12月25日股价下跌0.2%
华纳药厂最新公告:收到重酒石酸去甲肾上腺素注射液药品注册证书
证券之星 · 2025-12-25
华纳药厂最新公告:收到重酒石酸去甲肾上腺素注射液药品注册证书
华纳药厂(688799)披露关于获得药品注册证书的公告,12月22日股价上涨3.12%
证券之星 · 2025-12-22
华纳药厂(688799)披露关于获得药品注册证书的公告,12月22日股价上涨3.12%
加载更多
公司概况
公司名称:
湖南华纳大药厂股份有限公司
所属行业:
医药制造业
上市日期:
2021-07-13
主营业务:
湖南华纳大药厂股份有限公司的主营业务是化学原料药、化学药制剂和中药制剂的研发、生产与销售。公司的主要产品是制剂、原料药及中间体、植物提取物及食品。2024年,公司凭借持续的科技创新和研发投入,荣获中国证券报颁发的“新质企业金牛奖”、每日经济新闻主办的第十三届中国上市公司峰会“大健康最具成长上市公司”。
发行价格:
30.82
{"stockData":{"symbol":"688799","market":"SH","secType":"STK","nameCN":"华纳药厂","latestPrice":53.99,"timestamp":1774594801000,"preClose":49.06,"halted":0,"volume":12234424,"delay":0,"changeRate":0.1005,"floatShares":131000000,"shares":131000000,"eps":1.6223,"marketStatus":"已收盘","change":4.93,"latestTime":"03-27 15:00:01","open":48.09,"high":56,"low":48.09,"amount":652000000,"amplitude":0.1612,"askPrice":54,"askSize":1325,"bidPrice":53.99,"bidSize":80,"shortable":0,"etf":0,"ttmEps":1.6223,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774834200000},"marketStatusCode":5,"adr":0,"adjPreClose":49.06,"symbolType":"stock_kcb","openAndCloseTimeList":[[1774575000000,1774582200000],[1774587600000,1774594800000]],"highLimit":53.97,"lowLimit":44.15,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":131320000,"isCdr":false,"pbRate":3.56,"roa":"--","peRate":33.279911,"roe":"11.01%","epsLYR":1.75,"committee":-0.536394,"marketValue":7090000000,"turnoverRate":0.0932,"status":0,"afterMarket":{"amount":0,"volume":0,"close":53.99,"buyVolume":1046,"sellVolume":0,"time":1774596837558,"indexStatus":"已收盘 03-27 15:30:00","preClose":49.06},"floatMarketCap":7090000000},"requestUrl":"/m/hq/s/688799","defaultTab":"news","newsList":[{"id":"2622849847","title":"3月27日华纳药厂涨10.05%,安信医药健康股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2622849847","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622849847?lang=zh_cn&edition=full","pubTime":"2026-03-27 16:14","pubTimestamp":1774599278,"startTime":"0","endTime":"0","summary":"证券之星消息,3月27日华纳药厂涨10.05%创60日新高,收盘报53.99元,换手率9.32%,成交量12.23万手,成交额6.52亿元。重仓华纳药厂的公募基金请见下表:该股最近90天内共有2家机构给出评级,买入评级2家。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共7家,其中持有数量最多的公募基金为安信基金的安信医药健康股票A。安信医药健康股票A目前规模为3.62亿元,最新净值1.3167,较上一交易日下跌1.13%,近一年上涨38.54%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032700033414.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688799","BK0239"],"gpt_icon":0},{"id":"2621930590","title":"华纳药厂(688799)披露控股股东增加一致行动人及在一致行动人内部协议转让股份暨权益变动的提示性公告,3月24日股价上涨1.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621930590","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621930590?lang=zh_cn&edition=full","pubTime":"2026-03-24 22:27","pubTimestamp":1774362444,"startTime":"0","endTime":"0","summary":"截至2026年3月24日收盘,华纳药厂报收于44.78元,较前一交易日上涨1.8%,最新总市值为58.81亿元。近日,华纳药厂披露《关于控股股东增加一致行动人及在一致行动人内部协议转让股份暨权益变动的提示性公告》。转让完成后,华纳医药持股比例由39.78%降至31.34%,华纳至臻持股8.44%。本次权益变动尚需上交所合规性确认及办理过户登记,存在不确定性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400040013.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688799","BK0239"],"gpt_icon":0},{"id":"2621406930","title":"华纳药厂最新公告:获得二甲双胍恩格列净片药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2621406930","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621406930?lang=zh_cn&edition=full","pubTime":"2026-03-24 19:11","pubTimestamp":1774350667,"startTime":"0","endTime":"0","summary":"华纳药厂(688799.SH)公告称,公司近日收到国家药监局核准签发的二甲双胍恩格列净片(V)《药品注册证书》。该药品为化学药品4类,视同通过一致性评价,适用于正在接受恩格列净和盐酸二甲双胍治疗的2型糖尿病成人患者。公司表示,该产品获批将进一步丰富制剂品种、优化产品结构,但不会对公司近期业绩产生重大影响,未来销售受政策、市场及竞争等多重因素影响,存在不确定性。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400033843.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688799","BK0239"],"gpt_icon":0},{"id":"2621791533","title":"每周股票复盘:华纳药厂(688799)子公司通过美国FDA现场检查","url":"https://stock-news.laohu8.com/highlight/detail?id=2621791533","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621791533?lang=zh_cn&edition=full","pubTime":"2026-03-22 03:30","pubTimestamp":1774121435,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘,华纳药厂报收于43.81元,较上周的43.4元上涨0.94%。本周关注点公司公告汇总:子公司通过美国FDA现场检查,检查结果为VAI。近日公司收到FDA签发的现场检查报告,确认检查结束且子公司通过检查,检查结果为VAI。该结果表明子公司在生产管理质量体系、合规运营等方面符合FDA要求,对公司经营业绩和国际市场竞争具有积极影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032200001347.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688799","BK0239"],"gpt_icon":0},{"id":"2619456085","title":"华纳药厂(688799)披露关于子公司通过美国FDA现场检查的公告,XX月XX日股价上涨0.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619456085","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619456085?lang=zh_cn&edition=full","pubTime":"2026-03-16 17:29","pubTimestamp":1773653390,"startTime":"0","endTime":"0","summary":"截至2026年3月16日收盘,华纳药厂报收于43.57元,较前一交易日上涨0.39%,最新总市值为57.22亿元。今日,华纳药厂发布了自愿披露关于子公司通过美国FDA现场检查的公告。公告显示,公司全资子公司湖南华纳大药厂手性药物有限公司于2025年11月10日至11月14日接受了美国FDA的药品批准前检查,涉及产品为泮托拉唑钠原料药。该结果表明子公司在生产管理质量体系、合规运营等方面符合FDA要求,对公司经营业绩和国际市场竞争具有积极影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031600024393.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688799","BK0239"],"gpt_icon":0},{"id":"2619080061","title":"华纳药厂最新公告:子公司手性药物公司通过美国FDA现场检查","url":"https://stock-news.laohu8.com/highlight/detail?id=2619080061","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619080061?lang=zh_cn&edition=full","pubTime":"2026-03-15 16:39","pubTimestamp":1773563969,"startTime":"0","endTime":"0","summary":"华纳药厂(688799.SH)公告称,公司全资子公司湖南华纳大药厂手性药物有限公司于2025年11月10日至14日接受了美国FDA的药品批准前检查(PAI),近日收到FDA签发的现场检查报告(EIR),确认检查已结束,手性药物公司通过本次现场检查。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031500006147.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688799"],"gpt_icon":0},{"id":"2616843480","title":"每周股票复盘:华纳药厂(688799)子公司获巴西GMP认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2616843480","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616843480?lang=zh_cn&edition=full","pubTime":"2026-03-01 02:13","pubTimestamp":1772302390,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘,华纳药厂报收于44.36元,较上周的45.33元下跌2.14%。本周,华纳药厂2月24日盘中最高价报45.68元。2月27日盘中最低价报44.0元。华纳药厂当前最新总市值58.25亿元,在化学制药板块市值排名89/150,在两市A股市值排名3235/5189。该认证有助于产品进入巴西市场,拓展国际市场,提升公司国际竞争力。但国际原料药业务受政策和市场环境影响存在不确定性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100000708.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688799","BK0239","159100"],"gpt_icon":0},{"id":"2613736974","title":"股市必读:华纳药厂发布2025年度业绩快报,盈利2.415亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2613736974","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613736974?lang=zh_cn&edition=full","pubTime":"2026-02-24 01:16","pubTimestamp":1771866969,"startTime":"0","endTime":"0","summary":"截至2026年2月13日收盘,华纳药厂报收于45.33元,下跌2.52%,换手率2.17%,成交量2.85万手,成交额1.31亿元。业绩披露要点业绩快报华纳药厂近日即将发布2025年年报,根据2月13日发布的业绩快报,归属净利润盈利2.415亿元,同比增长46.95%。湖南华纳大药厂股份有限公司发布2025年度业绩快报,报告期内实现营业总收入151,559.43万元,同比增长7.26%;营业利润24,513.09万元,同比增长51.53%;归属于母公司所有者的净利润24,146.73万元,同比增长46.95%。采购周期至2028年12月31日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400007036.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688799"],"gpt_icon":0},{"id":"2611114391","title":"每周股票复盘:华纳药厂(688799)2025年净利增46.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611114391","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611114391?lang=zh_cn&edition=full","pubTime":"2026-02-15 01:31","pubTimestamp":1771090268,"startTime":"0","endTime":"0","summary":"截至2026年2月13日收盘,华纳药厂报收于45.33元,较上周的47.56元下跌4.69%。本周,华纳药厂2月9日盘中最高价报48.23元。华纳药厂当前最新总市值59.53亿元,在化学制药板块市值排名84/150,在两市A股市值排名3090/5189。业绩披露要点业绩快报华纳药厂预计发布2025年年报,归属净利润为2.415亿元,同比增长46.95%。2025年度业绩快报公告2025年度营业总收入为151,559.43万元,同比增长7.26%;营业利润为24,513.09万元,同比增长51.53%;归属于母公司所有者的净利润为24,146.73万元,同比增长46.95%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021500000293.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688799","BK0239"],"gpt_icon":0},{"id":"2611131320","title":"华纳药厂(688799.SH)2025年度归母净利润2.41亿元,同比增长46.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611131320","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611131320?lang=zh_cn&edition=full","pubTime":"2026-02-13 16:10","pubTimestamp":1770970235,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华纳药厂(688799.SH)披露2025年度业绩快报,2025年度实现营业收入15.16亿元,同比增长7.26%;归属于母公司所有者的净利润2.41亿元,同比增长46.95%。报告期内,公司营业收入增长主要系公司制剂产品、原料药及中间体产品销售收入增长以及技术服务收入增长共同所致;归属于母公司所有者的净利润增加主要是受投资收益影响;归属于母公司所有者的扣除非经常性损益的净利润下滑主要是因为计提股权激励费用影响,剔除股权激励费用影响后,归属于母公司所有者的扣除非经常性损益的净利润为1.82亿元,较上年同期增加31.57%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405139.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"华纳药厂(688799.SH)2025年度归母净利润2.41亿元,同比增长46.95%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688799"],"gpt_icon":0},{"id":"2610949043","title":"华纳药厂(688799.SH)参与国家组织集采药品协议期满品种接续采购拟中选","url":"https://stock-news.laohu8.com/highlight/detail?id=2610949043","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610949043?lang=zh_cn&edition=full","pubTime":"2026-02-12 17:51","pubTimestamp":1770889870,"startTime":"0","endTime":"0","summary":"华纳药厂(688799.SH)发布公告,近日,公司参加了国家组织集采药品协议期满品种接续采购办公室组织的国家组织集采药品协议期满品种接续采购。根据接续采购办公室发布的《国家组织集采药品协议期满品种接续采购拟中选结果公示》,公司蒙脱石散等部分药品拟中选本次接续采购。","market":"us","thumbnail":"https://img.zhitongcaijing.com/astock/23.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/23.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1404729.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["688799","BK0239"],"gpt_icon":0},{"id":"2609692525","title":"每周股票复盘:华纳药厂(688799)ZG-002片Ⅰ期临床研究完成","url":"https://stock-news.laohu8.com/highlight/detail?id=2609692525","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609692525?lang=zh_cn&edition=full","pubTime":"2026-02-08 01:55","pubTimestamp":1770486913,"startTime":"0","endTime":"0","summary":"截至2026年2月6日收盘,华纳药厂报收于47.56元,较上周的47.3元上涨0.55%。本周,华纳药厂2月6日盘中最高价报48.85元。华纳药厂当前最新总市值62.46亿元,在化学制药板块市值排名83/150,在两市A股市值排名2967/5186。本周关注点公司公告汇总:参股公司ZG-002片Ⅰ期临床研究完成,安全性与耐受性良好。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020800000463.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688799"],"gpt_icon":0},{"id":"2609216433","title":"华纳药厂(688799.SH)参股公司收到ZG-002片Ⅰ期临床研究报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2609216433","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609216433?lang=zh_cn&edition=full","pubTime":"2026-02-05 15:57","pubTimestamp":1770278225,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华纳药厂 发布公告,公司参股公司上海致根医药科技有限公司自主研发的ZG-002片在国家药品监督管理局同意下开展Ⅰ期临床试验已于近期完成,并于近期收到临床研究报告。ZG-002是致根医药自主开发的具有全新结构的新型抗自身免疫性疾病的药物,属于1类新药。ZG-002目前拟用于治疗中重度斑块状银屑病。本次临床试验的目的主要是评估ZG-002片在健康成年受试者中的安全性和耐受性、药代动力学特征及食物影响等。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4551","BK4548","BK4079","ZG","688799","BK0239"],"gpt_icon":0},{"id":"2606780054","title":"华纳药厂(688799)披露关于撤回利多卡因凝胶贴膏药品注册申请的公告,1月27日股价下跌2.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606780054","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606780054?lang=zh_cn&edition=full","pubTime":"2026-01-27 22:25","pubTimestamp":1769523919,"startTime":"0","endTime":"0","summary":"截至2026年1月27日收盘,华纳药厂报收于47.95元,较前一交易日下跌2.8%,最新总市值为62.97亿元。该股当日开盘49.38元,最高49.45元,最低47.05元,成交额达2.63亿元,换手率为4.2%。湖南华纳大药厂股份有限公司近日收到国家药品监督管理局核准签发的《药品注册申请终止通知书》,同意公司撤回利多卡因凝胶贴膏的注册申请。此次撤回不会对公司当期及未来生产经营与业绩产生重大影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012700041933.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688799"],"gpt_icon":0},{"id":"2605468049","title":"1月22日华纳药厂涨6.52%,安信医药健康股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2605468049","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605468049?lang=zh_cn&edition=full","pubTime":"2026-01-22 15:35","pubTimestamp":1769067350,"startTime":"0","endTime":"0","summary":"证券之星消息,1月22日华纳药厂涨6.52%,收盘报50.35元,换手率5.77%,成交量7.58万手,成交额3.74亿元。重仓华纳药厂的公募基金请见下表:该股最近90天内共有3家机构给出评级,买入评级3家。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共4家,其中持有数量最多的公募基金为安信基金的安信医药健康股票A。安信医药健康股票A目前规模为3.62亿元,最新净值1.497,较上一交易日上涨0.6%,近一年上涨74.07%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200019624.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688799"],"gpt_icon":0},{"id":"2595745418","title":"【机构调研记录】农银汇理基金调研华纳药厂","url":"https://stock-news.laohu8.com/highlight/detail?id=2595745418","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595745418?lang=zh_cn&edition=full","pubTime":"2025-12-31 08:11","pubTimestamp":1767139911,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及12月30日披露的机构调研信息,农银汇理基金近期对1家上市公司进行了调研,相关名单如下:1)华纳药厂 调研纪要:2025年前三季度,公司实现营业收入10.86亿元,同比增长1.55%;实现归属于上市公司股东的净利润2.07亿元,同比增长30.75%。农银汇理基金成立于2008年,截至目前,资产管理规模2197.3亿元,排名36/212;资产管理规模1378.96亿元,排名37/212;管理公募基金数139只,排名58/212;旗下公募基金经理27人,排名50/212。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123100008196.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688799"],"gpt_icon":0},{"id":"2594294781","title":"华纳药厂(688799)披露变更注册资本及公司治理结构调整公告,12月26日股价下跌2.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594294781","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594294781?lang=zh_cn&edition=full","pubTime":"2025-12-26 22:48","pubTimestamp":1766760496,"startTime":"0","endTime":"0","summary":"近日,湖南华纳大药厂股份有限公司召开2025年第二次临时股东大会,审议通过了关于变更注册资本、取消监事会、调整董事会人数、修订《公司章程》并办理工商变更登记的议案,以及修订公司部分治理制度的相关子议案。北京市康达律师事务所对本次会议进行了见证,并出具法律意见书,确认会议的召集和召开程序、召集人和出席人员资格、表决程序及表决结果均符合相关法律法规及公司章程的规定,会议合法有效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122600036826.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000860.SH","BK0239","688799"],"gpt_icon":0},{"id":"2594237029","title":"华纳药厂(688799)披露关于获得药品注册证书的公告,12月25日股价下跌0.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594237029","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594237029?lang=zh_cn&edition=full","pubTime":"2025-12-25 22:47","pubTimestamp":1766674038,"startTime":"0","endTime":"0","summary":"截至2025年12月25日收盘,华纳药厂报收于49.0元,较前一交易日下跌0.2%,最新总市值为64.35亿元。该股当日开盘48.88元,最高49.13元,最低48.06元,成交额达6112.77万元,换手率为0.95%。公司近日发布公告称,湖南华纳大药厂股份有限公司近日收到国家药品监督管理局核准签发的重酒石酸去甲肾上腺素注射液《药品注册证书》,批准该产品注册并发放药品注册证书。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500036389.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688799","BK0239"],"gpt_icon":0},{"id":"2594361432","title":"华纳药厂最新公告:收到重酒石酸去甲肾上腺素注射液药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2594361432","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594361432?lang=zh_cn&edition=full","pubTime":"2025-12-25 18:01","pubTimestamp":1766656877,"startTime":"0","endTime":"0","summary":"华纳药厂(688799.SH)公告称,公司收到国家药品监督管理局核准签发的重酒石酸去甲肾上腺素注射液《药品注册证书》,该药品用于急性低血压状态的血压恢复,也可用于心跳骤停的辅助治疗和心跳骤停复苏后的血压维持。该药品注册证书的取得进一步丰富了公司制剂产品品种,但未来销售情况可能受到政策变化、市场需求、同类型药品市场竞争等多种因素影响,具有不确定性。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500027086.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688799","BK0239"],"gpt_icon":0},{"id":"2593772433","title":"华纳药厂(688799)披露关于获得药品注册证书的公告,12月22日股价上涨3.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593772433","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593772433?lang=zh_cn&edition=full","pubTime":"2025-12-22 22:27","pubTimestamp":1766413638,"startTime":"0","endTime":"0","summary":"截至2025年12月22日收盘,华纳药厂报收于49.84元,较前一交易日上涨3.12%,最新总市值为65.45亿元。该股当日开盘48.57元,最高50.33元,最低48.13元,成交额达1.24亿元,换手率为1.91%。公司近日发布公告称,湖南华纳大药厂股份有限公司近日收到国家药品监督管理局核准签发的盐酸异丙肾上腺素注射液《药品注册证书》,批准该产品注册并发放药品注册证书。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122200034758.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688799"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1774608124855,"stockEarnings":[{"period":"1week","weight":0.1112},{"period":"1month","weight":0.104},{"period":"3month","weight":0.0238},{"period":"6month","weight":-0.1341},{"period":"1year","weight":0.7094},{"period":"ytd","weight":0.0285}],"compareEarnings":[{"period":"1week","weight":-0.0293},{"period":"1month","weight":-0.0555},{"period":"3month","weight":-0.0188},{"period":"6month","weight":0.0159},{"period":"1year","weight":0.1545},{"period":"ytd","weight":-0.0201}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"湖南华纳大药厂股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"6416人(较上一季度减少11.83%)","perCapita":"20467股","listingDate":"2021-07-13","address":"湖南省长沙市浏阳市生物医药园区","registeredCapital":"13132万元","survey":" 湖南华纳大药厂股份有限公司的主营业务是化学原料药、化学药制剂和中药制剂的研发、生产与销售。公司的主要产品是制剂、原料药及中间体、植物提取物及食品。2024年,公司凭借持续的科技创新和研发投入,荣获中国证券报颁发的“新质企业金牛奖”、每日经济新闻主办的第十三届中国上市公司峰会“大健康最具成长上市公司”。","listedPrice":30.82},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华纳药厂(688799)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华纳药厂(688799)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华纳药厂,688799,华纳药厂股票,华纳药厂股票老虎,华纳药厂股票老虎国际,华纳药厂行情,华纳药厂股票行情,华纳药厂股价,华纳药厂股市,华纳药厂股票价格,华纳药厂股票交易,华纳药厂股票购买,华纳药厂股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华纳药厂(688799)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华纳药厂(688799)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}